Home » Newsletters » BioWorld

BioWorld

Dec. 4, 1996

View Archived Issues

CATS, DOGS CHECK OUT NEW CANCER GENE THERAPY

ISIS GETS FIRST $10M MILESTONE IN BOEHRINGER INGELHEIM ANTISENSE PACT

ALTEON AMENDS PHASE III TRIAL PROTOCOL FOR PIMAGEDINE DUE TO ADVERSE

ATHENA NEUROSCIENCES' ZANAFLEX GETS FDA MARKETING APPROVAL

CHEMGENICS SIGNS POTENTIAL $70M DEAL WITH AMERICAN HOME PRODUCTS

SMITHKLINE BEECHAM, IDEC BEGIN PHASE III TRIALS OF RHEUMATOID